Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a Heart-to-Heart talk keep dialysis patients on track?

NCT ID NCT05735743

Disease control Sponsor: Vanderbilt University Medical Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether motivational interviewing, a counseling style that encourages patients to find their own reasons for change, can help African American adults on hemodialysis attend all their sessions. 176 participants will either receive the coaching or standard care, and researchers will track how many dialysis sessions are shortened or missed over 24 weeks.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
motivational interviewing (behavioral intervention)
What this could lead to
If it works, this could offer a simple, talk-based way to help more people complete their dialysis sessions, potentially improving health outcomes.
What could go wrong
This is a behavioral study with no drug; results depend on patient engagement and may not apply to all groups. The trial is relatively small and early-stage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

176 people

The number who actually took part.

Started

Oct 2023

Expected to finish

Nov 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * African American * Receiving hemodialysis treatments * Been on hemodialysis for more than 30 days * 18 years of age and older * Within a 2-month look back at the time of screening, patients who have missed at least one dialysis session or shortened at least one dialysis session by 15 minutes. Exclusion Criteria: * Not self-identified as African American * Impaired with mental status or severe illness * Non-English speaking * No documented evidence of dialysis treatment non-adherence * Missed or shortened treatments due to hospitalizations or excused travel * Terminal condition * Living in a nursing home/rehab * Planned transplant within the next 6 months * Planned conversion to peritoneal dialysis within the next 6 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for End stage renal disease on dialysis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

End stage renal disease on dialysis

Contacts and locations

Locations

  • Buttonwood DaVita Dialysis 449 N Broad St,

    Philadelphia, PA 19123, Pennsylvania, 19123, United States

  • DaVita Philadelphia PMC Dialysis

    Philadelphia, Pennsylvania, 19104, United States

  • DaVita University City Dialysis

    Philadelphia, Pennsylvania, 19104, United States

  • Dialysis Clinic, Inc.

    Nashville, Tennessee, 37208, United States

  • Vanderbilt Dialysis Clinic

    Nashville, Tennessee, 37204, United States

  • Vanderbilt Dialysis Clinic East

    Nashville, Tennessee, 37214, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.